William Blair Downgrades Amedisys (AMED) to Market Perform
Tweet Send to a Friend
(Updated - July 1, 2024 7:06 AM EDT)
William Blair analyst Matt Larew downgraded Amedisys (NASDAQ: AMED) from Outperform ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
William Blair analyst Matt Larew downgraded Amedisys (NASDAQ: AMED) from Outperform ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
